Bioasis Technologies Past Earnings Performance
Past criteria checks 0/6
Bioasis Technologies has been growing earnings at an average annual rate of 17.5%, while the Biotechs industry saw earnings growing at 12.7% annually. Revenues have been growing at an average rate of 614.1% per year.
Key information
17.5%
Earnings growth rate
20.0%
EPS growth rate
| Biotechs Industry Growth | 17.0% |
| Revenue growth rate | 614.1% |
| Return on equity | n/a |
| Net Margin | -1,067.6% |
| Last Earnings Update | 30 Nov 2022 |
Recent past performance updates
No updates
Recent updates
Revenue & Expenses BreakdownBeta
How Bioasis Technologies makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Nov 22 | 0 | -3 | 2 | 0 |
| 31 Aug 22 | 0 | -3 | 2 | 0 |
| 31 May 22 | 0 | -3 | 2 | 0 |
| 28 Feb 22 | 0 | -3 | 2 | 0 |
| 30 Nov 21 | 0 | -3 | 2 | 0 |
| 31 Aug 21 | 0 | -1 | 2 | -1 |
| 31 May 21 | 4 | 1 | 2 | 0 |
| 28 Feb 21 | 4 | 1 | 2 | 0 |
| 30 Nov 20 | 4 | 1 | 2 | 0 |
| 31 Aug 20 | 4 | 0 | 2 | 1 |
| 31 May 20 | 0 | -4 | 2 | 2 |
| 29 Feb 20 | 1 | -4 | 3 | 2 |
| 30 Nov 19 | 1 | -4 | 4 | 2 |
| 31 Aug 19 | 2 | -4 | 4 | 2 |
| 31 May 19 | 2 | -3 | 5 | 2 |
| 28 Feb 19 | 1 | -3 | 4 | 2 |
| 30 Nov 18 | 1 | -5 | 5 | 2 |
| 31 Aug 18 | 0 | -6 | 5 | 2 |
| 31 May 18 | 0 | -6 | 5 | 1 |
| 28 Feb 18 | 1 | -5 | 4 | 1 |
| 30 Nov 17 | 1 | -3 | 3 | 1 |
| 31 Aug 17 | 1 | -3 | 2 | 1 |
| 31 May 17 | 1 | -3 | 2 | 1 |
| 28 Feb 17 | 1 | -3 | 2 | 1 |
| 30 Nov 16 | 1 | -3 | 2 | 1 |
| 31 Aug 16 | 0 | -3 | 2 | 1 |
| 31 May 16 | 1 | -3 | 2 | 1 |
| 29 Feb 16 | 0 | -3 | 2 | 1 |
| 30 Nov 15 | 0 | -3 | 2 | 1 |
| 31 Aug 15 | 0 | -3 | 2 | 1 |
| 31 May 15 | 0 | -3 | 2 | 1 |
| 28 Feb 15 | 0 | -3 | 1 | 1 |
| 30 Nov 14 | 0 | -3 | 2 | 2 |
| 31 Aug 14 | 0 | -4 | 2 | 2 |
| 31 May 14 | 0 | -4 | 2 | 2 |
| 28 Feb 14 | 0 | -4 | 2 | 2 |
| 30 Nov 13 | 0 | -4 | 2 | 2 |
| 31 Aug 13 | 0 | -4 | 2 | 2 |
Quality Earnings: BIOA.F is currently unprofitable.
Growing Profit Margin: BIOA.F is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: Insufficient data to determine if BIOA.F's year-on-year earnings growth rate was positive over the past 5 years.
Accelerating Growth: Unable to compare BIOA.F's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: BIOA.F is unprofitable, making it difficult to compare its past year earnings growth to the Biotechs industry (-14%).
Return on Equity
High ROE: BIOA.F's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.